FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282563050> ?p ?o ?g. }

• W4282563050 endingPage "918" @default.
• W4282563050 startingPage "918" @default.
• W4282563050 abstract "Purpose: To report the clinical characteristics of ocular adverse events that have occurred, in China, after vaccination with inactivated COVID-19 vaccines. Methods: A retrospective cross-sectional observational study was conducted of ocular disorders that occurred within 15 days from any dose of an inactivated COVID-19 vaccine. Information on gender, age, the interval between the vaccination and ocular symptoms, laterality, duration of the ocular symptoms, primary visual acuity, and clinical diagnosis were retrospectively collected. Results: Twenty-four patients were involved in the study, including 15 females and 9 males, with a mean age of 41 ± 16 years (range of 8−71 years). The patients all denied a prior history of COVID-19 infection. Ocular adverse events occurred after the first dose of vaccine in 18 patients and, after the second or third doses, in six patients. The interval between vaccination with the inactivated COVID-19 vaccine and ocular symptoms was 6 ± 5 days; six patients were bilaterally involved and 18 patients were unilaterally involved. Regarding the diagnosis, 10 patients were diagnosed with white dot syndrome (WDS), 9 patients were diagnosed with uveitis, and 5 patients were diagnosed with retinal vascular disorders. The ages of patients with WDS were younger than those with uveitis or retinal vascular disorders (32 ± 10 vs. 48 ± 18, p < 0.05). For patients diagnosed with WDS, the best-corrected visual acuity (BCVA) was 0.74 ± 0.73 LogMAR. For patients diagnosed with retinal vascular disorders or uveitis, the BCVA was 1.44 ± 1.26 LogMAR. There was no significant difference (p > 0.05). Conclusions: A relationship cannot be established between inactivated COVID-19 vaccines and ocular disorders; therefore, further investigation of the clinical spectrum of ocular adverse events after vaccination with an inactivated COVID-19 vaccine is necessary." @default.
• W4282563050 created "2022-06-14" @default.
• W4282563050 creator A5001720031 @default.
• W4282563050 creator A5002568596 @default.
• W4282563050 creator A5013152328 @default.
• W4282563050 creator A5014942240 @default.
• W4282563050 creator A5022789841 @default.
• W4282563050 creator A5035520440 @default.
• W4282563050 creator A5053838397 @default.
• W4282563050 creator A5058051780 @default.
• W4282563050 creator A5060711016 @default.
• W4282563050 creator A5069302280 @default.
• W4282563050 creator A5072552137 @default.
• W4282563050 date "2022-06-09" @default.
• W4282563050 modified "2023-10-05" @default.
• W4282563050 title "Ocular Adverse Events after Inactivated COVID-19 Vaccination" @default.
• W4282563050 cites W1949880033 @default.
• W4282563050 cites W1986094681 @default.
• W4282563050 cites W2001532245 @default.
• W4282563050 cites W2017160691 @default.
• W4282563050 cites W2049532432 @default.
• W4282563050 cites W2056489903 @default.
• W4282563050 cites W2072201298 @default.
• W4282563050 cites W2133429650 @default.
• W4282563050 cites W2518536270 @default.
• W4282563050 cites W2522364850 @default.
• W4282563050 cites W2609522512 @default.
• W4282563050 cites W2904115191 @default.
• W4282563050 cites W2936794433 @default.
• W4282563050 cites W2955068995 @default.
• W4282563050 cites W3012439109 @default.
• W4282563050 cites W3013706373 @default.
• W4282563050 cites W3035706118 @default.
• W4282563050 cites W3047600127 @default.
• W4282563050 cites W3092766467 @default.
• W4282563050 cites W3102328262 @default.
• W4282563050 cites W3109698038 @default.
• W4282563050 cites W3119180698 @default.
• W4282563050 cites W3128702325 @default.
• W4282563050 cites W3153601187 @default.
• W4282563050 cites W3198258149 @default.
• W4282563050 cites W3200090586 @default.
• W4282563050 cites W3200281801 @default.
• W4282563050 cites W3207750139 @default.
• W4282563050 cites W3216843936 @default.
• W4282563050 cites W3217167717 @default.
• W4282563050 cites W4200033547 @default.
• W4282563050 cites W4206533230 @default.
• W4282563050 cites W4210467484 @default.
• W4282563050 cites W4214607432 @default.
• W4282563050 cites W4220718498 @default.
• W4282563050 cites W4221040445 @default.
• W4282563050 cites W4225263765 @default.
• W4282563050 doi "https://doi.org/10.3390/vaccines10060918" @default.
• W4282563050 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35746527" @default.
• W4282563050 hasPublicationYear "2022" @default.
• W4282563050 type Work @default.
• W4282563050 citedByCount "8" @default.
• W4282563050 countsByYear W42825630502022 @default.
• W4282563050 countsByYear W42825630502023 @default.
• W4282563050 crossrefType "journal-article" @default.
• W4282563050 hasAuthorship W4282563050A5001720031 @default.
• W4282563050 hasAuthorship W4282563050A5002568596 @default.
• W4282563050 hasAuthorship W4282563050A5013152328 @default.
• W4282563050 hasAuthorship W4282563050A5014942240 @default.
• W4282563050 hasAuthorship W4282563050A5022789841 @default.
• W4282563050 hasAuthorship W4282563050A5035520440 @default.
• W4282563050 hasAuthorship W4282563050A5053838397 @default.
• W4282563050 hasAuthorship W4282563050A5058051780 @default.
• W4282563050 hasAuthorship W4282563050A5060711016 @default.
• W4282563050 hasAuthorship W4282563050A5069302280 @default.
• W4282563050 hasAuthorship W4282563050A5072552137 @default.
• W4282563050 hasBestOaLocation W42825630501 @default.
• W4282563050 hasConcept C118487528 @default.
• W4282563050 hasConcept C126322002 @default.
• W4282563050 hasConcept C167135981 @default.
• W4282563050 hasConcept C187212893 @default.
• W4282563050 hasConcept C197934379 @default.
• W4282563050 hasConcept C203014093 @default.
• W4282563050 hasConcept C22070199 @default.
• W4282563050 hasConcept C2776194053 @default.
• W4282563050 hasConcept C2778257484 @default.
• W4282563050 hasConcept C71924100 @default.
• W4282563050 hasConceptScore W4282563050C118487528 @default.
• W4282563050 hasConceptScore W4282563050C126322002 @default.
• W4282563050 hasConceptScore W4282563050C167135981 @default.
• W4282563050 hasConceptScore W4282563050C187212893 @default.
• W4282563050 hasConceptScore W4282563050C197934379 @default.
• W4282563050 hasConceptScore W4282563050C203014093 @default.
• W4282563050 hasConceptScore W4282563050C22070199 @default.
• W4282563050 hasConceptScore W4282563050C2776194053 @default.
• W4282563050 hasConceptScore W4282563050C2778257484 @default.
• W4282563050 hasConceptScore W4282563050C71924100 @default.
• W4282563050 hasIssue "6" @default.
• W4282563050 hasLocation W42825630501 @default.
• W4282563050 hasLocation W42825630502 @default.
• W4282563050 hasLocation W42825630503 @default.
• W4282563050 hasLocation W42825630504 @default.

• next